These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 9173067)
1. [Characterization of nonresponders in high dosage UVA1 therapy of acute exacerbated atopic dermatitis]. Schempp CM; Effinger T; Czech W; Krutmann J; Simon JC; Schöpf E Hautarzt; 1997 Feb; 48(2):94-9. PubMed ID: 9173067 [TBL] [Abstract][Full Text] [Related]
2. High-dose UVA1 therapy in the treatment of patients with atopic dermatitis. Krutmann J; Czech W; Diepgen T; Niedner R; Kapp A; Schöpf E J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):225-30. PubMed ID: 1552057 [TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis. Abeck D; Schmidt T; Fesq H; Strom K; Mempel M; Brockow K; Ring J J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):254-7. PubMed ID: 10642681 [TBL] [Abstract][Full Text] [Related]
4. [Phototherapy in severe atopic dermatitis. Comparison between current UVA1 therapy, UVA1 cold light and combined UVA-UVB therapy]. von Kobyletzki G; Freitag M; Herde M; Höxtermann S; Stücker M; Hoffmann K; Altmeyer P Hautarzt; 1999 Jan; 50(1):27-33. PubMed ID: 10068928 [TBL] [Abstract][Full Text] [Related]
5. Mononuclear cells in atopic dermatitis in vivo: immunomodulation of the cutaneous infiltrate by medium-dose UVA1 phototherapy. Breuckmann F; von Kobyletzki G; Avermaete A; Pieck C; Kreuter A; Brockmeyer NH; Altmeyer P; Gambichler T Eur J Med Res; 2002 Jul; 7(7):315-22. PubMed ID: 12176681 [TBL] [Abstract][Full Text] [Related]
6. [UVA1 phototherapy. Pilot study of dose finding in acute exacerbated atopic dermatitis]. Dittmar HC; Pflieger D; Schöpf E; Simon JC Hautarzt; 2001 May; 52(5):423-7. PubMed ID: 11405161 [TBL] [Abstract][Full Text] [Related]
7. 'High dose' vs. 'medium dose' UVA1 phototherapy in italian patients with severe atopic dermatitis. Pacifico A; Iacovelli P; Damiani G; Ferraro C; Cazzaniga S; Conic RRZ; Leone G; Morrone A J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):718-724. PubMed ID: 30468530 [TBL] [Abstract][Full Text] [Related]
8. High-dose ultraviolet A1 (UVA1), but not UVA/UVB therapy, decreases IgE-binding cells in lesional skin of patients with atopic eczema. Grabbe J; Welker P; Humke S; Grewe M; Schöpf E; Henz BM; Krutmann J J Invest Dermatol; 1996 Sep; 107(3):419-22. PubMed ID: 8751980 [TBL] [Abstract][Full Text] [Related]
9. High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial. Krutmann J; Diepgen TL; Luger TA; Grabbe S; Meffert H; Sönnichsen N; Czech W; Kapp A; Stege H; Grewe M; Schöpf E J Am Acad Dermatol; 1998 Apr; 38(4):589-93. PubMed ID: 9555799 [TBL] [Abstract][Full Text] [Related]
10. Medium-dose ultraviolet (UV) A1 vs. narrowband UVB phototherapy in atopic eczema: a randomized crossover study. Gambichler T; Othlinghaus N; Tomi NS; Holland-Letz T; Boms S; Skrygan M; Altmeyer P; Kreuter A Br J Dermatol; 2009 Mar; 160(3):652-8. PubMed ID: 19120333 [TBL] [Abstract][Full Text] [Related]
11. Mast cells in atopic dermatitis: resistance against medium-dose UVA1 phototherapy? Breuckmann F; von Kobyletzki G; Avermaete A; Kreuter A; Altmeyer P; Gambichler T Dermatology; 2003; 207(3):334-6. PubMed ID: 14571085 [No Abstract] [Full Text] [Related]
12. [Responders and nonresponders of ultraviolet A-1 therapy of acute exacerbated atopic eczema]. Kowalzick L; Pönnighaus JM; Suckow M; Waldmann T Hautarzt; 1997 Sep; 48(9):645-7. PubMed ID: 9410849 [TBL] [Abstract][Full Text] [Related]
13. Medium-dose ultraviolet A1 phototherapy and mRNA expression of TSLP, TARC, IL-5, and IL-13 in acute skin lesions in atopic dermatitis. Bogaczewicz J; Malinowska K; Sysa-Jedrzejowska A; Wozniacka A Int J Dermatol; 2016 Aug; 55(8):856-63. PubMed ID: 26475182 [TBL] [Abstract][Full Text] [Related]
14. Medium-dose ultraviolet A1 phototherapy improves SCORAD index and increases mRNA expression of interleukin-4 without direct effect on human β defensin-1, interleukin-10, and interleukin-31. Bogaczewicz J; Malinowska K; Sysa-Jedrzejowska A; Wozniacka A Int J Dermatol; 2016 Jul; 55(7):e380-5. PubMed ID: 26748443 [TBL] [Abstract][Full Text] [Related]
15. Serum levels of anti-Staphylococcus aureus-specific IgE in patients with atopic dermatitis. Yamada H; Yudate T; Orita T; Tezuka T J Clin Lab Immunol; 1996; 48(4):167-75. PubMed ID: 9819668 [TBL] [Abstract][Full Text] [Related]
16. The effect of UVB radiation on skin microbiota in patients with atopic dermatitis and healthy controls. Dotterud LK; Wilsgaard T; Vorland LH; Falk ES Int J Circumpolar Health; 2008 Jun; 67(2-3):254-60. PubMed ID: 18767345 [TBL] [Abstract][Full Text] [Related]
17. Phototherapy in the management of atopic dermatitis: a systematic review. Meduri NB; Vandergriff T; Rasmussen H; Jacobe H Photodermatol Photoimmunol Photomed; 2007 Aug; 23(4):106-12. PubMed ID: 17598862 [TBL] [Abstract][Full Text] [Related]
19. Prevalence and role of serum IgE antibodies to the Staphylococcus aureus-derived superantigens SEA and SEB in children with atopic dermatitis. Bunikowski R; Mielke M; Skarabis H; Herz U; Bergmann RL; Wahn U; Renz H J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):119-24. PubMed ID: 9893195 [TBL] [Abstract][Full Text] [Related]
20. Sensitization to skin-associated microorganisms in adult patients with atopic dermatitis is of importance for disease severity. Sonesson A; Bartosik J; Christiansen J; Roscher I; Nilsson F; Schmidtchen A; Bäck O Acta Derm Venereol; 2013 May; 93(3):340-5. PubMed ID: 23073977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]